Literature DB >> 7870871

Development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the non-competitive NMDA receptor antagonist, MK-801.

J Stewart1, J P Druhan.   

Abstract

The non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist, MK-801, has been shown to block the development of sensitization of the behavioral activating effects of amphetamine. Three experiments were designed to determine in rats whether MK-801 had its effects through interference with long-term changes underlying sensitization, per se, or through interference with the development of conditioning of the drug effect to the environment where the drug was given. In experiment 1, conditioning was promoted by explicitly pairing amphetamine (1.5 mg/kg, IP) with the testing environment. In experiment 2, a random-pairing procedure was used to eliminate the possibility of association between the drug and a specific context. Experiment 3 was carried out to assess the duration of the blockade of sensitization by MK-801. The effect of MK-801 (0.25 mg/kg, IP) during amphetamine pre-exposure was studied in tests for conditioning (following saline injections, experiment 1) and in tests for sensitization (following 0.75 mg/kg amphetamine, experiments 1, 2 and 3). It was found in experiment 1 that MK-801 given with amphetamine during the amphetamine pre-exposure phase blocked the development of both conditioning activity and environment-specific sensitization to amphetamine. The results of experiment 2, showing that sensitization to amphetamine was blocked by MK-801 even when conditioning was prevented, suggest that the two effects of MK-801 are independent, and may implicate different sites of action.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7870871     DOI: 10.1007/bf02246961

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  38 in total

1.  Contributions of quisqualate and NMDA receptors to the induction and expression of LTP.

Authors:  D Muller; M Joly; G Lynch
Journal:  Science       Date:  1988-12-23       Impact factor: 47.728

2.  Stereospecific blockade of N-methyl-D-aspartate transmission by MK 801 prevents priming of SKF 38393-induced turning.

Authors:  M Morelli; G Di Chiara
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

3.  Tissue levels and in vivo release of tachykinins and GABA in striatum and substantia nigra of rat brain after unilateral striatal dopamine denervation.

Authors:  N Lindefors; E Brodin; U Tossman; J Segovia; U Ungerstedt
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

4.  Microinjections of Sch-23390 into the ventral tegmental area and substantia nigra pars reticulata attenuate the development of sensitization to the locomotor activating effects of systemic amphetamine.

Authors:  J Stewart; P Vezina
Journal:  Brain Res       Date:  1989-08-28       Impact factor: 3.252

5.  Latent sensitization to apomorphine following repeated low doses.

Authors:  B A Mattingly; J E Gotsick; K Salamanca
Journal:  Behav Neurosci       Date:  1988-08       Impact factor: 1.912

6.  The effect of dopamine receptor blockade on the development of sensitization to the locomotor activating effects of amphetamine and morphine.

Authors:  P Vezina; J Stewart
Journal:  Brain Res       Date:  1989-10-09       Impact factor: 3.252

7.  Neurotensin-dopamine interactions in the substantia nigra of the rat brain.

Authors:  K M Merchant; L G Bush; J W Gibb; G R Hanson
Journal:  J Pharmacol Exp Ther       Date:  1990-11       Impact factor: 4.030

8.  Amphetamine administered to the ventral tegmental area but not to the nucleus accumbens sensitizes rats to systemic morphine: lack of conditioned effects.

Authors:  P Vezina; J Stewart
Journal:  Brain Res       Date:  1990-05-14       Impact factor: 3.252

9.  Blocking of acquisition but not expression of conditioned fear-potentiated startle by NMDA antagonists in the amygdala.

Authors:  M J Miserendino; C B Sananes; K R Melia; M Davis
Journal:  Nature       Date:  1990-06-21       Impact factor: 49.962

10.  Excitatory amino acids in synaptic transmission in the Schaffer collateral-commissural pathway of the rat hippocampus.

Authors:  G L Collingridge; S J Kehl; H McLennan
Journal:  J Physiol       Date:  1983-01       Impact factor: 5.182

View more
  26 in total

1.  Genetic NMDA receptor deficiency disrupts acute and chronic effects of cocaine but not amphetamine.

Authors:  Amy J Ramsey; Aki Laakso; Michel Cyr; Tatyana D Sotnikova; Ali Salahpour; Ivan O Medvedev; Linda A Dykstra; Raul R Gainetdinov; Marc G Caron
Journal:  Neuropsychopharmacology       Date:  2008-01-09       Impact factor: 7.853

2.  Behavioral and neurochemical recovery from partial 6-hydroxydopamine lesions of the substantia nigra is blocked by daily treatment with D1/D5, but not D2, dopamine receptor antagonists.

Authors:  A Emmi; H Rajabi; J Stewart
Journal:  J Neurosci       Date:  1997-05-15       Impact factor: 6.167

3.  H3 receptor blockade by thioperamide enhances cognition in rats without inducing locomotor sensitization.

Authors:  Victoria A Komater; Kaitlin E Browman; Peter Curzon; Arthur A Hancock; Michael W Decker; Gerard B Fox
Journal:  Psychopharmacology (Berl)       Date:  2003-04-08       Impact factor: 4.530

4.  Evidence for dissociable mechanisms of amphetamine- and stress-induced behavioral sensitization: effects of MK-801 and haloperidol pretreatment.

Authors:  B K Tolliver; L B Ho; M S Reid; S P Berger
Journal:  Psychopharmacology (Berl)       Date:  1996-08       Impact factor: 4.530

5.  Psychostimulant drug effects on glutamate, Glx, and creatine in the anterior cingulate cortex and subjective response in healthy humans.

Authors:  Tara L White; Mollie A Monnig; Edward G Walsh; Adam Z Nitenson; Ashley D Harris; Ronald A Cohen; Eric C Porges; Adam J Woods; Damon G Lamb; Chelsea A Boyd; Sinda Fekir
Journal:  Neuropsychopharmacology       Date:  2018-03-06       Impact factor: 7.853

6.  Amphetamine blocks long-term synaptic depression in the ventral tegmental area.

Authors:  S Jones; J L Kornblum; J A Kauer
Journal:  J Neurosci       Date:  2000-08-01       Impact factor: 6.167

7.  A single exposure to amphetamine is sufficient to induce long-term behavioral, neuroendocrine, and neurochemical sensitization in rats.

Authors:  L J Vanderschuren; E D Schmidt; T J De Vries; C A Van Moorsel; F J Tilders; A N Schoffelmeer
Journal:  J Neurosci       Date:  1999-11-01       Impact factor: 6.167

8.  Cocaine behavioral sensitization and the excitatory amino acids.

Authors:  R Karler; L D Calder; J B Bedingfield
Journal:  Psychopharmacology (Berl)       Date:  1994-07       Impact factor: 4.530

9.  Behavioural and neurochemical adaptations to nicotine in rats: influence of NMDA antagonists.

Authors:  M Shoaib; M E Benwell; M T Akbar; I P Stolerman; D J Balfour
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

10.  Ontogeny of behavioral sensitization in the rat: effects of direct and indirect dopamine agonists.

Authors:  S A McDougall; M A Duke; C A Bolanos; C A Crawford
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.